Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive Outcome.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
05 05 2019
Historique:
received: 21 11 2018
accepted: 27 12 2018
pubmed: 1 1 2019
medline: 17 3 2020
entrez: 1 1 2019
Statut: ppublish

Résumé

Female reproductive tract microbiota may affect human reproduction. The current study considered whether a more detailed characterization of the vaginal microbiota could improve prediction of risk of poor reproductive outcome in patients undergoing in vitro fertilization (IVF). Vaginal samples from 120 patients undergoing IVF were sequenced using the V4 region of the 16S ribosomal RNA gene with clustering of Gardnerella vaginalis genomic clades. Abnormal vaginal microbiota was defined by microscopy and quantitative polymerase chain reaction (qPCR) for G. vaginalis and/or Atopobium vaginae above a threshold. Three major community state types with abundance of Lactobacillus crispatus, Lactobacillus iners, and a diverse community type were identified, including 2 subtypes, characterized by a high abundance of L. crispatus and L. iners, respectively, but in combination with common diversity type operational taxonomic units. No significant association between community state type and the reproductive outcome could be demonstrated; however, abnormal vaginal microbiota by qPCR and a grouping based on high Shannon diversity index predicted the reproductive outcome equally well. The predictive value of 16S ribosomal RNA gene sequencing was not superior to the simpler and less expensive qPCR diagnostic approach in predicting the risk of a poor reproductive outcome in patients undergoing IVF. NCT02042352.

Sections du résumé

BACKGROUND
Female reproductive tract microbiota may affect human reproduction. The current study considered whether a more detailed characterization of the vaginal microbiota could improve prediction of risk of poor reproductive outcome in patients undergoing in vitro fertilization (IVF).
METHODS
Vaginal samples from 120 patients undergoing IVF were sequenced using the V4 region of the 16S ribosomal RNA gene with clustering of Gardnerella vaginalis genomic clades. Abnormal vaginal microbiota was defined by microscopy and quantitative polymerase chain reaction (qPCR) for G. vaginalis and/or Atopobium vaginae above a threshold.
RESULTS
Three major community state types with abundance of Lactobacillus crispatus, Lactobacillus iners, and a diverse community type were identified, including 2 subtypes, characterized by a high abundance of L. crispatus and L. iners, respectively, but in combination with common diversity type operational taxonomic units. No significant association between community state type and the reproductive outcome could be demonstrated; however, abnormal vaginal microbiota by qPCR and a grouping based on high Shannon diversity index predicted the reproductive outcome equally well.
CONCLUSIONS
The predictive value of 16S ribosomal RNA gene sequencing was not superior to the simpler and less expensive qPCR diagnostic approach in predicting the risk of a poor reproductive outcome in patients undergoing IVF.
CLINICAL TRIALS REGISTRATION
NCT02042352.

Identifiants

pubmed: 30597027
pii: 5266799
doi: 10.1093/infdis/jiy744
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Banques de données

ClinicalTrials.gov
['NCT02042352']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1809-1817

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Thor Haahr (T)

Faculty of Health, Aarhus University, Copenhagen, Denmark.
Fertility Clinic Skive, Skive Regional Hospital, Copenhagen, Denmark.

Peter Humaidan (P)

Faculty of Health, Aarhus University, Copenhagen, Denmark.
Fertility Clinic Skive, Skive Regional Hospital, Copenhagen, Denmark.

Helle Olesen Elbaek (HO)

Faculty of Health, Aarhus University, Copenhagen, Denmark.
Fertility Clinic Skive, Skive Regional Hospital, Copenhagen, Denmark.

Birgit Alsbjerg (B)

Faculty of Health, Aarhus University, Copenhagen, Denmark.
Fertility Clinic Skive, Skive Regional Hospital, Copenhagen, Denmark.

Rita Jakubcionyte Laursen (RJ)

Faculty of Health, Aarhus University, Copenhagen, Denmark.
Fertility Clinic Skive, Skive Regional Hospital, Copenhagen, Denmark.

Kåre Rygaard (K)

Trianglen Fertility Clinic, Copenhagen, Denmark.

Thor Bech Johannesen (TB)

Statens Serum Institut, Copenhagen, Denmark.

Paal Skytt Andersen (PS)

Statens Serum Institut, Copenhagen, Denmark.

Kim Lee Ng (KL)

Statens Serum Institut, Copenhagen, Denmark.

Jørgen Skov Jensen (JS)

Statens Serum Institut, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH